12 Posts Not To Miss From Day 3 of ASCOBT24!
This Year the ASCO Breakthrough (ASCOBT24) was held in Yokohama, Japan from 8th to 10th of August, jointly organized by the Japan Society of Clinical Oncology (JSCO) and Japanese Society of Medical Oncology (JSMO). It focused on showcasing significant advancements and innovations in oncology.
As the event came to its end, here are some highlights from Day 3 of ASCOBT24 that you should not miss!
“Women at ASCOBT24 meet and greet – ‘Raising the Bamboo Ceiling'”
“How can Machine Learning be used to identify depression in patients with gynecological cancers? ASCO Expert in AI Dr. Julian Hong explains ASCOBT24 research on using voice recordings to screen for depression and how it’s a good first step for bringing technology into the cancer clinic. See the science.”
“We had very fruitful interactions and exchanges with city cancer care stakeholders and experts from the Asia-Pacific region over the past two days, held in conjunction with ascobt24 in Yokohama, Japan. Several immediate and near-future collaboration opportunities were identified. In a world that is virtually connected, face-to-face meetings still hold immense value.”
“Happening now ASCOBT24 Day 3
Rapid Oral: Real-World Evidence and AI/Health Tech
Trial on a novel CT-guided percutaneous transthoracic needle biopsy navigation system (RC120)
Speaker: Dr. Lei Wang”
“I am honored to have received the ASCO Breakthrough 2024 merit award and to have had the opportunity to present our findings orally. We anticipate that our research on the control of irAEs will make significant contributions to cancer treatments.”
“Very honoured to host Dr Shimon Sakaguchi of Tregs who delivered a wonderful lecture on Tregs in tumour immunity. Unbelievable how much we learnt in an hour on this topic. Grateful to ASCO for this opportunity to bring this knowledge to Asia.”
“Program Chair Melvin L. K. Chua opening Day 3 of ASCOBT24, with keynote Dr Shimon Sakaguchi dissecting Treg biology as a strategy of tumor immunity.”
“Happening now #ASCOBT24 Day 3
Real World Evidence and Clinical Trials Beyond the Ivory Tower
Evaluating Decentralized Trials (DCT) from Academic and Industry Perspectives.
Speaker: Janet Dancey.”
“Congratulations Melvin L. K. Chua, Lillian Siu, ASCO team for a wonderful meeting!
- love the focus on equity
- Love the rep from asia pacific crew
- Love the support for women in oncology and trainees
Safe travels home and see you ASCOBT25!”
“Great job by Dr Andrew Miles and Annie Wong discussing about management of melanoma. This is really a disease of Oceania and no people better than them to show us how it is done!”
“ASCOBT24 is almost over.
My thoughts
- thought-provoking meeting
- lots of new connections made
- work remains
- smashing bamboo ceiling
- advocating across regions
- training new leaders
- amplifying diverse voices
Bring on 2025 . Thank you Yokohama.”
“ASCOBT24 The last session and closing remarks for an inclusive and cutting edge conference with top level in-depth leaders presenting. The questions and discussion were truly inspiring in this ASCO conference – see you in Yokohama again in August 7-9 2025!”
For the latest updates on ASCOBT24, visit oncodaily.com
15 Posts Not To Miss From Day 1 of ASCOBT24
12 Posts Not To Miss From Day 2 of ASCOBT24